Family Medicine Doctors in Chamberlain, SD Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Chad J Carda, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 |
Mr. Joshua Wade Payer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 305-324-6551 Fax: 605-324-7260 |
John Boyd Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 |
Travis M Sanger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 |
Joel Eggers, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 160-523-4284 |
 Kaylyn Jean Doney, CNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 |
News Archive
Free CME course on cardiovascular disease to be held in Phoenix, Arizona
A Continuing Medical Education workshop, "Beating Cardiovascular Disease: Understanding the meaning and value of key risk factors, will be hosted in Phoenix, Arizona on May 14, 2011 by Dr. Sam Fillingane.
Research findings suggest new treatment for breast, colon, melanoma and other cancers
A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results.
Cell discovery could help fight against liver disease
Scientists have identified new sub-types of cells that, when they interact, accelerate the scarring process in diseased livers.
Calypso real-time tumor tracking system usage during IMRT for prostate cancer reduces rectal/urinary side effects
Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, "Assessing the Impact of Margin Reduction (AIM)," is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as "reduced treatment margins."
Annual benefits open enrollment period for AvMed Health Plans begins
It's that time of year again. The annual benefits open enrollment period for the majority of AvMed Health Plans' large group clients, (50 or more eligible employees), began September 1 and will continue through mid-December 2009.
› Verified 6 days ago